170 related articles for article (PubMed ID: 24523776)
1. Effect of Oral Anticoagulant Therapy on Coagulation Activity and Inflammatory Markers in Patients with Atrial Fibrillation Undergoing Ablation: A Randomized Comparison between Dabigatran and Warfarin.
Amini S; Gholami K; Bakhshandeh H; Fariborz Farsad B
Iran J Pharm Res; 2013; 12(4):945-53. PubMed ID: 24523776
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
Kaseno K; Naito S; Nakamura K; Sakamoto T; Sasaki T; Tsukada N; Hayano M; Nishiuchi S; Fuke E; Miki Y; Nakamura K; Yamashita E; Kumagai K; Oshima S; Tada H
Circ J; 2012; 76(10):2337-42. PubMed ID: 22785434
[TBL] [Abstract][Full Text] [Related]
3. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
[TBL] [Abstract][Full Text] [Related]
4. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
[TBL] [Abstract][Full Text] [Related]
5. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation].
Yang L; Gao LJ; Yin XM; Guo BL
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430
[No Abstract] [Full Text] [Related]
6. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
Nogami A; Harada T; Sekiguchi Y; Otani R; Yoshida Y; Yoshida K; Nakano Y; Nuruki N; Nakahara S; Goya M; Origasa H; Kihara Y; Hirao K; Aonuma K;
JAMA Netw Open; 2019 Apr; 2(4):e191994. PubMed ID: 31002317
[TBL] [Abstract][Full Text] [Related]
9. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
Ichiki H; Oketani N; Ishida S; Iriki Y; Okui H; Maenosono R; Namino F; Ninomiya Y; Miyata M; Hamasaki S; Tei C
Pacing Clin Electrophysiol; 2013 Nov; 36(11):1328-35. PubMed ID: 23952291
[TBL] [Abstract][Full Text] [Related]
10. The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
Li H; Zhang L; Xia M; Zhang C; Jiang T
Clin Appl Thromb Hemost; 2021; 27():10760296211044722. PubMed ID: 34559016
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic Responses After Catheter Ablation for Atrial Fibrillation During Uninterrupted Oral Anticoagulant Agent Administration.
Yanagisawa S; Inden Y; Fujii A; Sakamoto Y; Tomomatsu T; Mamiya K; Okamoto H; Shibata R; Murohara T
JACC Clin Electrophysiol; 2019 Dec; 5(12):1418-1427. PubMed ID: 31857041
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Nin T; Sairaku A; Yoshida Y; Kamiya H; Tatematsu Y; Nanasato M; Inden Y; Hirayama H; Murohara T
Pacing Clin Electrophysiol; 2013 Feb; 36(2):172-9. PubMed ID: 23121681
[TBL] [Abstract][Full Text] [Related]
13. Post-Procedural Dabigatran Versus Interrupted Warfarin Therapy Following Catheter Ablation for Atrial Fibrillation.
Lin Md J; Shen Md S; Bhave Md P; Knight Md B; Bohn Rn Bsn M; Giedrimas Md E; K Patel Md T; Chicos Md A; Goldberger Md J; Ilkhanoff Md Ms L; Kim Md S; Lin Md A; Passman Md Msce R
J Atr Fibrillation; 2014; 6(5):1000. PubMed ID: 27957045
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.
Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
Clin Drug Investig; 2013 Jun; 33(6):409-18. PubMed ID: 23572324
[TBL] [Abstract][Full Text] [Related]
15. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.
Stepanyan G; Badhwar N; Lee RJ; Marcus GM; Lee BK; Tseng ZH; Vedantham V; Olgin J; Scheinman M; Gerstenfeld EP
J Interv Card Electrophysiol; 2014 Jun; 40(1):33-8. PubMed ID: 24643666
[TBL] [Abstract][Full Text] [Related]
16. [The Use of Dabigatran for Prevention of Thromboembolic Complications in Patients Underwent Atrial Fibrillation Catheter Ablation].
Mamchur SE; Gorbunova EV; Sherbinina DA; Romanova MP
Kardiologiia; 2015; 55(4):30-5. PubMed ID: 26502500
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study.
Hohnloser SH; Calkins H; Willems S; Verma A; Schilling R; Okumura K; Nordaby M; Kleine E; Biss B; Gerstenfeld EP;
J Interv Card Electrophysiol; 2019 Aug; 55(2):145-152. PubMed ID: 30758702
[TBL] [Abstract][Full Text] [Related]
18. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
Siegbahn A; Oldgren J; Andersson U; Ezekowitz MD; Reilly PA; Connolly SJ; Yusuf S; Wallentin L; Eikelboom JW
Thromb Haemost; 2016 May; 115(5):921-30. PubMed ID: 26818781
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
Intern Med; 2015; 54(10):1167-73. PubMed ID: 25986252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
